LB714R
LIVE

Serial Number

79318652

Owner

L'ORÉAL

Attorney

Howard W. Kline

Filing Date

Jun 16, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LB714R Trademark

Serial Number: 79318652 • Registration: 6841510

LB714R is a trademark filed by L'ORÉAL on June 16, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

L'ORÉAL (86 trademarks)

14 Rue Royale
PARIS 75008 , FR

Entity Type: 33

Lactobio A/S (8 trademarks)

Lersø Parkallé 42, 2.

Entity Type: 84

Trademark Details

Filing Date

June 16, 2021

Registration Date

September 13, 2022

Published for Opposition

June 28, 2022

Goods & Services

Pharmaceutical preparations, namely, anti-inflammatory drugs; antimicrobial agents for dermatological use; antimicrobial agents for vaginal use; antifungal preparations and anti-yeast preparations for medical use; acne creams being pharmaceutical preparations; antibacterial preparations for acne; medicated antimicrobial mouthwashes; antimicrobial preparations for the treatment of acne, dermatitis, eczema, carbuncle, cellulitis, rosacea, psoriasis, diaper rash, impetigo, pimples, blisters, mycosis, wounds, urinary tract infection, vaginitis and candidiasis, all of the foregoing containing probiotics; antibacterial preparations for the treatment of acne, dermatitis, eczema, carbuncle, cellulitis, rosacea, psoriasis, diaper rash, impetigo, pimples, blisters, mycosis, wounds, urinary tract infection, vaginitis and candidiasis, all of the foregoing containing probiotics; antibiotic creams; antibiotic dermatological preparations; bacterial preparations for medical use; bacterial preparations for medical and veterinary use; bacteriological preparations for pharmaceutical use; bacteriological preparations for medical and veterinary use; biological preparations for medical purposes; biopesticides for agricultural purposes; biotechnological products for medical purposes, namely, reagents for medical use; mixed antibiotic preparations; medicated dermatological preparations; pharmaceutical skin lotions; pharmaceuticals for the epidermis; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of bacterial disorders; pharmaceutical preparations for treating diseases caused by bacteria; pharmaceutical preparations for skin care; nutritional supplements; medical skin care preparations, namely, creams; medicinal oils; medical dermatological preparations; probiotic bacterial mixtures for medical use; probiotic bacterial mixtures for veterinary purposes; probiotic supplements; sanitary preparations for medical purposes, namely, udder creams for use for agricultural purpose; probiotic medicinal preparations for maintaining the natural balance of the flora of the digestive system

Biological preparations for industrial and scientific purposes; formulations of probiotics not for medical use, namely, microbes for use in the manufacture of probiotic supplements; bacterial cultures, except for medical or veterinary use, namely, bacterial cultures for addition to food products and ingredients for cosmetics, cosmeceuticals, pharmaceuticals, food, food supplements beverages, veterinary preparations and cleaning preparations in the nature of probiotic bacteria, probiotic bacterial cultures and probiotic bacterial hydrolysates; bactericidal preparations, other than for medical or veterinary purposes, namely, bacterial cultures for addition to food products and ingredients for cosmetics, cosmeceuticals, pharmaceuticals, food, food supplements beverages, veterinary preparations and cleaning preparations in the nature of probiotic bacteria, probiotic bacterial cultures and probiotic bacterial hydrolysates; bacterial cultures for use as food additives; bacterial substances being bacterial preparations for industrial purposes; bacterial preparations for the food industry; bacterial preparations, except for medical and veterinary use; bacteria for use in food manufacture; probiotic bacterial cultures for the food industry; bacteriological preparations for use in agriculture

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jul 24, 2025 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 9, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 15, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 15, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
ASSIGNED TO LIE
May 20, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 18, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 18, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 18, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 18, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2022 TROA
REFUSAL PROCESSED BY IB
May 10, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 15, 2022 RFCS
REFUSAL PROCESSED BY MPU
Apr 15, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2022 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 8, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 31, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 26, 2021 REPR